Moore Capital Management’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,500
Closed -$1.84M 806
2022
Q2
$1.84M Hold
7,500
0.05% 350
2022
Q1
$2.19M Hold
7,500
0.06% 357
2021
Q4
$1.58M Hold
7,500
0.03% 423
2021
Q3
$2.43M Hold
7,500
0.04% 421
2021
Q2
$2.64M Hold
7,500
0.04% 401
2021
Q1
$2.88M Buy
7,500
+3,750
+100% +$1.62M 0.04% 382
2020
Q4
$1.51M Sell
3,750
-1,875
-33% -$811K 0.02% 380
2020
Q3
$2.38M Sell
5,625
-625
-10% -$284K 0.05% 251
2020
Q2
$3.19M Buy
+6,250
New +$3.07M 0.09% 170

Other funds holding CFRX

Moore Capital Management's CFRX Position: Q3 2022 in Review

Moore Capital Management sold out of ContraFect Corporation (CFRX) in Q3 2022, closing a stake of 7,500 shares — an estimated $1.84M sold.

Moore Capital Management first reported a position in CFRX in Q2 2020 and held it in 9 quarters. The position peaked at $3.19M in Q2 2020. 46 funds tracked by Wall St. Rank hold CFRX as of Q3 2022.

  • Moore Capital Management reported no remaining ContraFect Corporation position as of Q3 2022 after selling out during the quarter.
  • Moore Capital Management sold 7,500 ContraFect Corporation shares in Q3 2022, an estimated $1.84M.
  • Moore Capital Management first reported a position in ContraFect Corporation in Q2 2020 and held it in 9 quarters.
  • Moore Capital Management's ContraFect Corporation position peaked at $3.19M in Q2 2020.
  • 46 funds tracked by Wall St. Rank held ContraFect Corporation as of Q3 2022.

Based on Moore Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.